Metabolomics of Roux-en-Y Gastric Bypass (RYGB) With Gastrostomy

University of North Carolina System

Status: Completed

Conditions: Type II Diabetes Mellitus; Obesity

Treatments: Procedure: Gastrostomy Tube; Procedure: Gastric Band; Procedure: Gastric Sleeve

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT00887302

J&J Ethicon

Details and patient eligibility

About

This study is an investigation of the "metabolomics of RYGB with gastrostomy."

Full description

The rapid and durable remission of type II diabetes mellitis following the gastric bypass operation challenges the current concepts about the etiology of the disease. The surgery, which excludes food from the stomach, duodenum, and proximal jejunum, is quickly followed by a durable drop in glucose and insulin levels. As a result, 4 out of 5 diabetic, morbidly obese individuals who undergo the operation return to a long-term euglycemia with a prolongation of life and a reduction of health care costs.

The investigators at East Carolina University and those at Johnson and Johnson propose to further complete the profile of the upper gut by extending their observation to three additional human models. The investigators will study patients having the gastric band procedure, the gastric sleeve procedure, and those who have a gastric bypass but have a PEG tube inserted later.

Enrollment: 13 patients

Sex: Female

Ages: 18 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Female
• 18-60 years of age
• BMI of 35-65
• Willing to comply with study requirements and long term follow-up
• Capable of understanding the requirements and consequences of surgery and the study
• Is scheduled to have bariatric surgery performed
• Has a negative pregnancy test

Exclusion criteria

• Repeat gastric bypass procedure
• Patients who are unable to hold their insulin coverage for 48 hours prior to research visits
• Patients taking TZDs

Trial design

13 participants in 3 patient groups

Restricted food intake without rerouting food flow cohort

Description:

Obese non-diabetic patients and diabetic patients undergoing gastric band surgery will be studied before they have surgery, 1 week after the band is adjusted to restrict food intake and again after they have lost the weight equal to that which gastric bypass patients loose 3 months after surgery (to match data we already have in the current study). All patients will be studied with an intravenous glucose tolerance test to measure insulin sensitivity and IV glucose-induced insulin secretion and a meal challenge to measure the secretion of metabolites and peptides.

Treatment:

Procedure: Gastric Band

Response to meal when a portion of the stomach is excluded from food flow cohort

Description:

Obese-diabetic patient undergoing gastric sleeve surgery will be studied before they have surgery, 1 week after surgery and again 3-6 months after surgery (to match data we already have in the current study). The patient will be studied with an intravenous glucose tolerance test to measure insulin sensitivity and insulin secretion and a meal challenge to measure the secretion of metabolites and peptides.

Treatment:

Procedure: Gastric Sleeve

Response to meal when a portion of the GI tract is excluded from food flow cohort

Description:

In approximately 6 patients/year our surgeons have to insert a gastrostomy tube into the bypassed stomach of gastric bypass patients. This provides a unique opportunity to see the changes in metabolites and peptides in blood in response to a meal delivered to the bypassed stomach, duodenum and proximal jejunum. Since we can not anticipate which patients will require this procedure, we cannot do tests before surgery, but we will do four tests post-operatively: (1) an IV glucose tolerance test, (2) an oral meal challenge (with Hi-cal), and (3) a meal challenge (identical to that given orally/Hi-Cal) delivered through the gastrostomy tube. Gastrostomy subjects will also have a 4) test, a 75 gram dextrose meal challenge.

Treatment:

Procedure: Gastrostomy Tube